Inpatient vs Delayed Readmission for Coronary Artery Bypass Grafting After Non-ST Elevation Myocardial Infarction

Michael A Catalano1, Yu Zhao2, Omar Toubat1

  • 1Division of Cardiovascular Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania.

Insights

Optimal timing for coronary artery bypass grafting (CABG) after non-ST-elevation myocardial infarction (NSTEMI) is 2-4 days post-diagnosis. Inpatient CABG is generally preferred over delayed surgery due to lower mortality risks.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Health Services Research

Background:

  • The optimal timing for coronary artery bypass grafting (CABG) following non-ST-elevation myocardial infarction (NSTEMI) is not well-established.
  • National practice patterns and outcomes for CABG timing after NSTEMI require further investigation.

Purpose of the Study:

  • To assess national practice patterns and outcomes of CABG timing following NSTEMI.
  • To compare inpatient versus delayed CABG strategies and analyze specific inpatient timing.

Main Methods:

  • A retrospective analysis of Medicare beneficiaries (≥65 years) with NSTEMI undergoing diagnostic angiography (10/2016-10/2021).
  • Propensity-score matching compared inpatient CABG with delayed elective CABG within three months.
  • Primary endpoint: 30-day mortality; Secondary endpoint: 4-year survival. Logistic regression with natural cubic splines analyzed inpatient CABG timing (0-1, 2-3, 4-7, >7 days).

Main Results:

  • Out of 704,638 patients, 27.1% underwent inpatient CABG and 2.3% had delayed elective CABG.
  • Propensity-matched analysis showed lower 30-day mortality for delayed elective CABG (3.6% vs. 4.9%, p<0.001), but similar 4-year survival.
  • Among discharged patients, 1.3% required urgent CABG (30-day mortality=6.3%), and 9.1% died within three months without revascularization.
  • Inpatient CABG demonstrated optimal short-term outcomes when performed 2-4 days post-angiography.

Conclusions:

  • Performing CABG 2-4 days after NSTEMI diagnosis is associated with optimal outcomes.
  • While delayed elective CABG shows short-term survival benefits in selected patients, most NSTEMI patients benefit from inpatient revascularization due to risks of mortality and urgent intervention after discharge.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...